Stimulation for treating sleep disordered breathing
Summary
Inspire Medical Systems core stimulation patent covering the method and device architecture for treating obstructive sleep apnea by electrically stimulating an upper-airway-patency-related nerve using a stimulation protocol with defined stimulation and non-stimulation periods. Covers the implantable stimulation element, respiratory sensing, and protocol that define Inspire's core commercial product. Inventors: Darrell Wagner, Quan Ni, John Rondoni, David Dieken. Granted January 26, 2021.
Why it matters
US10898709 is currently named in active patent litigation between Inspire Medical and Nyxoah in US District Court for Delaware (Case 1:25-cv-00667) and PTAB IPR2026-00091 — confirming its commercial centrality to Inspire's $912M revenue platform. USPTO officially announced the grant in January 2021.
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trial